Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 21:00 source : Www.allogene.com save search
8-K: Report of unscheduled material events or corporate event
Published: 2023-06-07 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.17%
H: 0.69%
C: -0.51%
report
8-K: Report of unscheduled material events or corporate event
Published: 2023-05-03 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.35%
H: 20.53%
C: 13.16%
report
10-Q: Quarterly report which provides a continuing view of a company's financial position
Published: 2023-05-03 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.35%
H: 20.53%
C: 13.16%
report financial
DEFA14A: Additional proxy soliciting materials – definitive
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
defa14
DEF 14A: Official notification to shareholders of matters to be brought to a vote (“Proxy”)
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
ARS: An annual report to security holders
Published: 2023-04-24 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: 0.0%
H: 9.68%
C: 4.28%
report security
Allogene Therapeutics Appoints Timothy Moore as Chief Technical Officer
Published: 2023-04-20 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.8%
H: 10.81%
C: 9.29%
therapeutics moore
8-K: Report of unscheduled material events or corporate event
Published: 2023-04-20 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.8%
H: 10.81%
C: 9.29%
report
8-K: Report of unscheduled material events or corporate event
Published: 2022-11-29 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: 1.29%
H: 5.41%
C: 4.56%
report
Allogene Therapeutics Reports Third Quarter 2022 Financial Results and Announces Investor R&D Showcase
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -7.47%
H: 4.2%
C: 1.17%
therapeutics financial results
8-K: Report of unscheduled material events or corporate event
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -7.47%
H: 4.2%
C: 1.17%
report
10-Q: Quarterly report which provides a continuing view of a company's financial position
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -7.47%
H: 4.2%
C: 1.17%
report financial
S-3ASR: S-3ASR
Published: 2022-11-02 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -7.47%
H: 4.2%
C: 1.17%
4: Statement of changes in beneficial ownership of securities
Published: 2022-10-11 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.27%
H: 2.18%
C: 1.09%
Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Published: 2022-10-06 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.64%
H: 12.12%
C: -4.87%
trial therapeutics phase 2
8-K: Report of unscheduled material events or corporate event
Published: 2022-10-06 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.64%
H: 12.12%
C: -4.87%
report
4: Statement of changes in beneficial ownership of securities
Published: 2022-10-05 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: 0.0%
H: 3.99%
C: 1.67%
SC TO-I/A: Amendment to a previously filed SC TO-I
Published: 2022-07-20 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -0.71%
H: 3.29%
C: 2.86%
8-K: Report of unscheduled material events or corporate event
Published: 2022-07-12 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
report
SC TO-I/A: Amendment to a previously filed SC TO-I
Published: 2022-07-12 (Crawled : 21:00) - allogene.com
ALLO | $3.505 1.3% 130K
|
Health Technology
|
| O: -2.16%
H: 9.96%
C: 7.84%
Gainers vs Losers
| 84% | 16% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.